Literature DB >> 28630052

Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases.

Guillermo Rodríguez-Hernández1,2, Julia Hauer3, Alberto Martín-Lorenzo1,2, Daniel Schäfer3, Christoph Bartenhagen4, Idoia García-Ramírez1,2, Franziska Auer3, Inés González-Herrero1,2, Lucia Ruiz-Roca1,2, Michael Gombert3, Vera Okpanyi3, Ute Fischer3, Cai Chen3, Martin Dugas4, Sanil Bhatia3, René Martin Linka3, Marta Garcia-Suquia5, María Victoria Rascón-Trincado5, Angel Garcia-Sanchez5,6, Oscar Blanco2,7, Maria Begoña García-Cenador2,8, Francisco Javier García-Criado2,8, César Cobaleda9, Diego Alonso-López10, Javier De Las Rivas2,10,11, Markus Müschen12, Carolina Vicente-Dueñas2, Isidro Sánchez-García1,2, Arndt Borkhardt13.   

Abstract

ETV6-RUNX1 is associated with the most common subtype of childhood leukemia. As few ETV6-RUNX1 carriers develop precursor B-cell acute lymphocytic leukemia (pB-ALL), the underlying genetic basis for development of full-blown leukemia remains to be identified, but the appearance of leukemia cases in time-space clusters keeps infection as a potential causal factor. Here, we present in vivo genetic evidence mechanistically connecting preleukemic ETV6-RUNX1 expression in hematopoetic stem cells/precursor cells (HSC/PC) and postnatal infections for human-like pB-ALL. In our model, ETV6-RUNX1 conferred a low risk of developing pB-ALL after exposure to common pathogens, corroborating the low incidence observed in humans. Murine preleukemic ETV6-RUNX1 pro/preB cells showed high Rag1/2 expression, known for human ETV6-RUNX1 pB-ALL. Murine and human ETV6-RUNX1 pB-ALL revealed recurrent genomic alterations, with a relevant proportion affecting genes of the lysine demethylase (KDM) family. KDM5C loss of function resulted in increased levels of H3K4me3, which coprecipitated with RAG2 in a human cell line model, laying the molecular basis for recombination activity. We conclude that alterations of KDM family members represent a disease-driving mechanism and an explanation for RAG off-target cleavage observed in humans. Our results explain the genetic basis for clonal evolution of an ETV6-RUNX1 preleukemic clone to pB-ALL after infection exposure and offer the possibility of novel therapeutic approaches. Cancer Res; 77(16); 4365-77. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28630052     DOI: 10.1158/0008-5472.CAN-17-0701

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  Genetic defects in hematopoietic transcription factors and predisposition to acute lymphoblastic leukemia.

Authors:  Yoshihiro Gocho; Jun J Yang
Journal:  Blood       Date:  2019-07-16       Impact factor: 22.113

2.  Lineage choice decisions in B-cell development and leukemia.

Authors:  Javier Raboso-Gallego; Ana Casado-García; Guillermo Rodríguez-Hernández; Carolina Vicente-Dueñas; Isidro Sánchez-García
Journal:  Stem Cell Investig       Date:  2018-12-07

3.  Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening.

Authors:  Daniel Schäfer; Marianne Olsen; David Lähnemann; Martin Stanulla; Robert Slany; Kjeld Schmiegelow; Arndt Borkhardt; Ute Fischer
Journal:  Blood       Date:  2018-01-08       Impact factor: 22.113

Review 4.  A causal mechanism for childhood acute lymphoblastic leukaemia.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2018-08       Impact factor: 60.716

5.  An intact gut microbiome protects genetically predisposed mice against leukemia.

Authors:  Carolina Vicente-Dueñas; Stefan Janssen; Marina Oldenburg; Franziska Auer; Inés González-Herrero; Ana Casado-García; Marta Isidro-Hernández; Javier Raboso-Gallego; Philipp Westhoff; Aleksandra A Pandyra; Daniel Hein; Katharina L Gössling; Diego Alonso-López; Javier De Las Rivas; Sanil Bhatia; Francisco Javier García-Criado; María Begoña García-Cenador; Andreas P M Weber; Karl Köhrer; Julia Hauer; Ute Fischer; Isidro Sánchez-García; Arndt Borkhardt
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

6.  T-cell leukemogenesis is an inappropriate lineage decision-making process: implications for precision oncology.

Authors:  Guillermo Rodríguez-Hernández; Sanil Bhatia; Carolina Vicente-Dueñas; Arndt Borkhardt; Julia Hauer; Isidro Sánchez-García
Journal:  Mol Cell Oncol       Date:  2018-08-07

Review 7.  Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.

Authors:  Cesar Cobaleda; Carolina Vicente-Dueñas; Isidro Sanchez-Garcia
Journal:  Nat Rev Immunol       Date:  2021-02-08       Impact factor: 53.106

Review 8.  Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Hiroto Inaba; Ching-Hon Pui
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

Review 9.  The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.

Authors:  Erica Dander; Chiara Palmi; Giovanna D'Amico; Giovanni Cazzaniga
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 10.  Cell Fate Decisions: The Role of Transcription Factors in Early B-cell Development and Leukemia.

Authors:  Ute Fischer; Jun J Yang; Tomokatsu Ikawa; Daniel Hein; Carolina Vicente-Dueñas; Arndt Borkhardt; Isidro Sánchez-García
Journal:  Blood Cancer Discov       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.